Abstract
In the April 1999 issue of Nephrology Dialysis Transplantation, there is an article which summarizes the report of the US task force convened to study the epidemic of cardiovascular disease in the haemodialysis population [1]. This task force, composed of prestigious experts, collectively made a report on what to do about the growing epidemic of cardiovascular disease in the haemodialysis population. On page 832, in the all important `treatment of hypertension' section, this summary article contains the following statement: `All classes of anti-hypertensive agents are effective with the exception of diuretics'. If that statement is true, how come greater than 65% of the world's haemodialysis patients are hypertensive [2–6]?